In previous study, Taketo et.al showed that METTL3 knockdown sensitized pancreatic cancer to multiple anti-cancer reagents, including gemcitabine, 5-fluorouracil, cisplatin and irradiation as well [21]. The gene discussed is METTL3; the disease is pancreatic neoplasm.